Table 2.
UC participant number, medications | HIVDVL participant number, medications | HIVNDVL participant number, medications | |||
---|---|---|---|---|---|
1 | Dicyclomine, metronidazole, prednisone | 1 | Lamivudine, nevirapine, tenofovir DF | 1 | Lamivudine/zidovudine, saquinavir, ritonavir, nevirapine |
2 | 5-ASA, prednisone, AZA, fludrocortisone | 2 | 5-ASA, lamivudine/zidovudine, tenofovir DF, efavirenz | 2 | Lamivudine, lopinavir/ritonavir, tenofovir DF |
3 | Infliximab | 3 | 5-ASA, lamivudine/zidovudine, tenofovir DF, efavirenz | 3 | Abacavir/lamivudine/zidovudine, tenofovir DF |
4 | Infliximab, prednisone | 4 | No medications | 4 | Lamivudine/zidovudine, efavirenz, acyclovir |
5 | Unknown | 5 | No medications | 5 | No medications |
6 | 5-ASA | 6 | Emtricitabine/tenofovir DF/efavirenz | 6 | Raltegravir, lopinavir/ritonavir, etravirine |
7 | 5-ASA | 7 | No medications | 7 | Lamivudine, didanosine, nevirapine, stavudine |
8 | Fish oil | 8 | No medications | 8 | Lamivudine/zidovudine, saquinavir, nelfinavir |
9 | 5-ASA, prednisone, 6-MP | 9 | Lopinavir/ritonavir, tenofovir DF, abacavir | 9 | Lamivudine, stavudine, tenofovir DF |
10 | Lopinavir/ritonavir, lamivudine | 10 | Lamivudine, stavudrine, efavirenz |
HIV-infected participants were stratified according to detectable plasma viral load (HIVDVL) vs. nondetectable plasma viral load (HIVNDVL).
5-ASA, 5-aminosalicylic acid; AZA, azathioprine; 6-MP, 6-mercaptopurine; DF, disoproxil fumarate.